On January 18, Leap Therapeutics Inc. (LPTX) announced its upcoming presentation about new positive data from its DisTinGuish study. Consequently, the stock became bullish in
On the last check Wednesday, shares of the biotechnology company focused on developing targeted and immuno-oncology therapeutics, Leap Therapeutics Inc. (LPTX) was up 12.24% at
Leap Therapeutics Inc. (NASDAQ: LPTX) stock gained by 3.36% in the last trading close whereas the LPTX stock is surging by 34.96% during the pre-market
Oncternal Therapeutics Inc. (ONCT) stock soared 2.42% to $2.96 in the pre-market trading as the company raised the size of the formerly publicized offering and
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.